Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics.

OBJECTIVE To examine the presence of human papillomavirus (HPV) in breast cancer tissues. DESIGN AND METHODS Four different PCR methods for detection and verification of genital HPVs were applied in frozen breast cancer specimens. Tumors were also evaluated for various histopathological parameters. RESULTS Seventeen samples out of 107 tested positive (15.9%). HPV RFLP typing identified a total of 21 high-risk viruses: fourteen HPV 16 (67% of all detected HPV types), three HPV 59, two HPV 58, one HPV 73 and one HPV 82 (one sample with double infection and two samples with triple infection). Breast cancer patients harboring high-risk HPV DNA sequences in their tumor were younger than the rest of the patients. Furthermore, they were less estrogen-receptor-positive and more proliferative as observed in the corresponding indices: Ki-67 staining, S-phase/proliferative fractions and percentage of cells with DNA content over 5C. CONCLUSION The presence of high-risk HPV DNA sequences in the breast cancer tissues studied was verified, and a possible association with acceleration of malignancy was examined.

[1]  Goberdhan P Dimri,et al.  Mammary epithelial cell transformation: insights from cell culture and mouse models , 2005, Breast Cancer Research.

[2]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[3]  R. E. Sandstrom,et al.  Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast , 2004, Breast Cancer Research.

[4]  Harald zur Hausen,et al.  Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis , 2000 .

[5]  S. Beaudenon,et al.  Genital papillomavirus in Greek women with high‐grade cervical intraepithelial neoplasia and cervical carcinoma , 1996, Journal of medical virology.

[6]  G. Sheu,et al.  The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. , 2001, Cancer research.

[7]  D. Yannoukakos,et al.  Genetic counseling of medullary breast cancer patients , 2004, Clinical genetics.

[8]  S. Kern,et al.  Sodium boric acid: a Tris-free, cooler conductive medium for DNA electrophoresis. , 2004, BioTechniques.

[9]  Rachid Karam,et al.  Evidence for an Association of Human Papillomavirus and Breast Carcinomas , 2004, Breast Cancer Research and Treatment.

[10]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[11]  J. T. Lumeij,et al.  Avian Clinical Biochemistry , 1997 .

[12]  R. Rondez,et al.  Determination of nuclear DNA content and hormone receptors in breast cancer by the CAS 100 cell analysis system as related to morphologic grade and biochemical results. , 1991, Analytical and quantitative cytology and histology.

[13]  J. Lawson,et al.  From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis , 2000, Breast Cancer Research.

[14]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[15]  I. Kato,et al.  Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. , 1991, The Journal of general virology.

[16]  M. Manos,et al.  42 – DETECTION AND TYPING OF GENITAL HUMAN PAPILLOMAVIRUSES , 1990 .

[17]  Jahn M. Nesland,et al.  Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). , 2004, Breast Cancer Research and Treatment.

[18]  Thomas J. White,et al.  PCR protocols: a guide to methods and applications. , 1990 .

[19]  C. Peyton,et al.  Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. , 1994, The Journal of infectious diseases.

[20]  J. Schiller,et al.  New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. , 2002, Journal of the National Cancer Institute.

[21]  R. Coombes,et al.  Absence of HPV 16 and 18 DNA in breast cancer. , 1992, British Journal of Cancer.

[22]  C. Meijer,et al.  The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. , 1995, The Journal of general virology.